StockWatch
·

AAREY DRUGS & PHARMACEUTICALS LTD.

BSE: 524412

Shareholding Trends

Ownership split

PromoterPublicOthers
0%23%47%70%Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27

Institutional detail

FII / FPIDII
0%2%4%5%Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27

Q1 FY27

Corporate Events

Board MeetingAAREYDRUGS
2026
14Nov

Board Meeting

To consider and approve the Unaudited Financial Result along…

BSE Filing ↗
Board MeetingAAREYDRUGS
2026
30Sep

Board Meeting

The 36th Annual General Meeting of the Company is scheduled …

BSE Filing ↗
Board MeetingAAREYDRUGS
2026
5Sep

Board Meeting

The Board of Directors considered and approved the Draft of …

BSE Filing ↗
Board MeetingAAREYDRUGS
2026
14Aug

Board Meeting

To consider and approve the Unaudited Financial Result along…

BSE Filing ↗
Board MeetingAAREYDRUGS
2026
6Aug

Board Meeting

The Board of Directors of the Company approved the allotment…

BSE Filing ↗
Board MeetingAAREYDRUGS
2026
29May

Board Meeting

To consider and approve the Audited Financial Results for th…

BSE Filing ↗
Board MeetingAAREYDRUGS
2025
30May

Board Meeting

Consider and approve the Audited Financial statement for the…

BSE Filing ↗
Board MeetingAAREYDRUGS
2025
14Feb

Board Meeting

consider and approve Unaudited Financial statement for the q…

BSE Filing ↗
Board MeetingAAREYDRUGS
2024
14Nov

Board Meeting

Consider and approve the Unaudited Financial statement for t…

BSE Filing ↗
Board MeetingAAREYDRUGS
2024
1Oct

Board Meeting

Allotment

BSE Filing ↗
Board MeetingAAREYDRUGS
2024
14Aug

Board Meeting

Consider and approve the Unaudited Financial statement for t…

BSE Filing ↗
Board MeetingAAREYDRUGS
2024
30May

Board Meeting

consider and approve the Audited Financial statement for the…

BSE Filing ↗